ASSETS HELD FOR SALE

6 Months Ended

Dec. 31, 2016

Notes to Financial Statements

ASSETS HELD FOR SALE

NOTE 3. ASSETS HELD FOR SALE

On January 27, 2017, we sold certain of the assets and the business operations of our OMS division located in Beaverton Oregon. We sold the business to our long time general manager of the division. The sale was structured as an asset sale as disclosed in a Form 8-K filed with the SEC on January 30, 2017. The aggregate sales price received was $640,000, subject to adjustment based upon the value of the OMS receivables at the date of close and no liabilities other than warranty obligations were assumed by the buyer. As a result of the sale, this division has been classified as a discontinued operation in conformity with applicable accounting guidance and the assets that were sold have been reclassified as assets held for sale on our condensed consolidated balance sheets. Accordingly, unless otherwise indicated, OMS’s results have been reported as discontinued operations and removed from all financial discussions of continuing operations.

The following summarizes the carrying values of the assets sold as of each respective balance sheet date (in thousands):

	December 31, 2016		June 30, 2016
Assets held for sale:
Inventory	$	242	$	209
Fixed assets		57		64
Prepaid expenses		2		5
Other assets		9		9
Assets held for sale	$	310	$	287

The divestiture was completed in support of raising capital to invest in our core medical device product development efforts.

Operating results of the OMS division are as follows (in thousands):

	Three Months Ended December 31,					Six Months Ended December 31,
	2016		2015			2016		2015
Revenues	$	381	$	208		$	664	$	512
Income (loss) from discontinued operations:
Income (loss) from discontinued operations, before taxes	$	97	$	(90	)	$	96	$	(143	)
Income tax expense		38		—			38		—
Net income (loss) from discontinued operations	$	59	$	(90	)	$	58	$	(143	)

Income from discontinued operations consists of direct revenues and direct expenses of the OMS business, including cost of revenues, as well as other fixed costs to the extent that such costs will be eliminated as a result of the sale. The Company historically did not allocate corporate overhead to this division. Additionally, the OMS division has historically been the only division that was significant enough to require segment disclosures and as such, effective with this divestiture, we no longer require segment disclosure as our business is currently run.